Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.8, 2013-08, pp. : 1025-1035

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

By Sartori Arianna Carle Dawn Freedman Mark S

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1019-1027

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1219-1228

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 621-630

Informa Healthcare

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina Kappos Ludwig Sprenger Till

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

Current Neuropharmacology, Vol. 15, Iss. 6, 2017-07 ,pp. : 874-891

Bentham Science Publishers

Access to resources Recommend Favorite